103 related articles for article (PubMed ID: 10758575)
21. Interleukins and STAT signaling.
Haque SJ; Sharma P
Vitam Horm; 2006; 74():165-206. PubMed ID: 17027515
[TBL] [Abstract][Full Text] [Related]
22. Roles of unphosphorylated STATs in signaling.
Yang J; Stark GR
Cell Res; 2008 Apr; 18(4):443-51. PubMed ID: 18364677
[TBL] [Abstract][Full Text] [Related]
23. MR image-guided investigation of regional signal transducers and activators of transcription-1 activation in a rat model of focal cerebral ischemia.
West DA; Valentim LM; Lythgoe MF; Stephanou A; Proctor E; van der Weerd L; Ordidge RJ; Latchman DS; Gadian DG
Neuroscience; 2004; 127(2):333-9. PubMed ID: 15262323
[TBL] [Abstract][Full Text] [Related]
24. Phosphorylation and activation of STAT proteins by hypoxia in breast cancer cells.
Lee MY; Joung YH; Lim EJ; Park JH; Ye SK; Park T; Zhang Z; Park DK; Lee KJ; Yang YM
Breast; 2006 Apr; 15(2):187-95. PubMed ID: 16084091
[TBL] [Abstract][Full Text] [Related]
25. Constitutive activation of stat 3 oncogene product in human ovarian carcinoma cells.
Huang M; Page C; Reynolds RK; Lin J
Gynecol Oncol; 2000 Oct; 79(1):67-73. PubMed ID: 11006034
[TBL] [Abstract][Full Text] [Related]
26. Serine phosphorylation of STATs.
Decker T; Kovarik P
Oncogene; 2000 May; 19(21):2628-37. PubMed ID: 10851062
[TBL] [Abstract][Full Text] [Related]
27. [Activation of signal transducers and activators of transcription induced by vascular endothelial growth factor in CD34+ hematopoietic progenitor cells in vitro].
Ye F; Ye DF; Xie X; Chen HZ; Lü WG
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Feb; 26(1):12-7. PubMed ID: 15052767
[TBL] [Abstract][Full Text] [Related]
28. Opposing actions of STAT-1 and STAT-3.
Stephanou A; Latchman DS
Growth Factors; 2005 Sep; 23(3):177-82. PubMed ID: 16243709
[TBL] [Abstract][Full Text] [Related]
29. Molecular characterization of STAT signaling in inflammation and tumorigenesis.
Adach A; Ellert-Miklaszewska A; Kaminska B
Methods Mol Biol; 2009; 512():265-78. PubMed ID: 19347282
[TBL] [Abstract][Full Text] [Related]
30. A novel type-1 cytokine receptor from fish involved in the Janus kinase/signal transducers and activators of transcription (Jak/STAT) signal pathway.
Santos MD; Yasuike M; Kondo H; Hirono I; Aoki T
Mol Immunol; 2007 Jul; 44(13):3355-63. PubMed ID: 17383728
[TBL] [Abstract][Full Text] [Related]
31. Acetylation modulates the STAT signaling code.
Wieczorek M; Ginter T; Brand P; Heinzel T; Krämer OH
Cytokine Growth Factor Rev; 2012 Dec; 23(6):293-305. PubMed ID: 22795479
[TBL] [Abstract][Full Text] [Related]
32. Comparative screening and validation as a novel tool to identify STAT-specific inhibitors.
Szeląg M; Czerwoniec A; Wesoly J; Bluyssen HA
Eur J Pharmacol; 2014 Oct; 740():417-20. PubMed ID: 25183399
[TBL] [Abstract][Full Text] [Related]
33. Oncogenic STAT Transcription Factors as Targets for Cancer Therapy: Innovative Strategies and Clinical Translation.
Wang W; Lopez McDonald MC; Hariprasad R; Hamilton T; Frank DA
Cancers (Basel); 2024 Mar; 16(7):. PubMed ID: 38611065
[TBL] [Abstract][Full Text] [Related]
34. Targeting signal transducers and activators of transcription (STAT) in human cancer by dietary polyphenolic antioxidants.
Amani H; Ajami M; Nasseri Maleki S; Pazoki-Toroudi H; Daglia M; Tsetegho Sokeng AJ; Di Lorenzo A; Nabavi SF; Devi KP; Nabavi SM
Biochimie; 2017 Nov; 142():63-79. PubMed ID: 28807562
[TBL] [Abstract][Full Text] [Related]
35. The role of STATs in proliferation, differentiation, and apoptosis.
Mui AL
Cell Mol Life Sci; 1999 Sep; 55(12):1547-58. PubMed ID: 10526572
[TBL] [Abstract][Full Text] [Related]
36. The competitive nature of signal transducer and activator of transcription complex formation drives phenotype switching of T cells.
Sadreev II; Chen MZQ; Umezawa Y; Biktashev VN; Kemper C; Salakhieva DV; Welsh GI; Kotov NV
Immunology; 2018 Apr; 153(4):488-501. PubMed ID: 29030870
[TBL] [Abstract][Full Text] [Related]
37. Screening approaches to generating STAT inhibitors: Allowing the hits to identify the targets.
Walker SR; Frank DA
JAKSTAT; 2012 Oct; 1(4):292-9. PubMed ID: 24058786
[TBL] [Abstract][Full Text] [Related]
38. Targeting STAT-3 signaling pathway in cancer for development of novel drugs: Advancements and challenges.
Arshad S; Naveed M; Ullia M; Javed K; Butt A; Khawar M; Amjad F
Genet Mol Biol; 2020; 43(1):e20180160. PubMed ID: 32167126
[TBL] [Abstract][Full Text] [Related]
39. Protein tyrosine phosphatases as wardens of STAT signaling.
Böhmer FD; Friedrich K
JAKSTAT; 2014 Jan; 3(1):e28087. PubMed ID: 24778927
[TBL] [Abstract][Full Text] [Related]
40. Overview of the STAT-3 signaling pathway in cancer and the development of specific inhibitors.
Gu Y; Mohammad IS; Liu Z
Oncol Lett; 2020 Apr; 19(4):2585-2594. PubMed ID: 32218808
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
